RFX6 and type 2 diabetes mellitus: Knockdown of RFX6 in beta-pancreatic cells not only resulted in substantial variation in gene expression, but also provided evidence of dysregulation of regulatory elements harboring T2D GWAS variants via changes in genome-wide chromatin states (Walker et al., 2023).